Short Summary
The Delhi High Court ruled in favor of ATC IP LLC, granting a permanent injunction against the operators of infringing domain names. The court found that the defendants' websites copied the plaintiffs' registered trademarks ('ATC', 'ATC India') and logos, causing potential misuse. Furthermore, the court ordered NIXI to facilitate the transfer of the infringing domain name www.atctower.in to ATC IP LLC, effectively resolving the dispute through summary judgment.
Detailed Summary
of the Paris Local Division of the Unified Patent Court concerning a request for extension of time filed by the Bosch defendants. The judge-rapporteur rejected Bosch's request, finding that a non-redacted version of Valeo's 15 June 2026 filing had been deposited in the CMS simultaneously with the redacted version, and that Bosch had failed to exercise due diligence in accessing it. The court ruled that the deadlines under R.29(d) RdP run from 15 June 2026.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before Delhi High Court - Orders. Understanding the court's reasoning in ATC IP LLC & Anr. vs Owner Of <Https://Atcindiatower. In/> & Ors is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
National Research DevelopmentvsSilicon Ceramics Ltd.
The petitioner (a Public Undertaking) sued the respondent for non-payment of royalty and interest on a license granted to manufacture semi-conductor packages. The dispute went through arbitration, which was subsequently challenged by the respondent on grounds including lack of jurisdiction and invalidity of the agreement due to non-registration under the Patents Act. The High Court upheld the arbitrator's award.
Ovid Therapeutics, Inc.vsAssistant Controller Of Patents And Designs
Ovid Therapeutics appealed a refusal order issued by the Assistant Controller of Patents and Designs regarding its patent application for 'Methods of Increasing Tonic Inhibition and Treating Secondary Insomnia'. The initial rejection cited multiple grounds, including non-patentability (Section 3(i) and 3(e)), lack of inventive step, and insufficient disclosure. Ovid Therapeutics argued that their composition offered a synergistic effect and provided novel dosage information not present in the prior art. This appeal challenges the Controller's decision to refuse patent protection for the pharmaceutical methods.
M/s Munjal Showa LimitedvsM/s Star India Private Limited
The Madras High Court addressed a batch of petitions concerning the rectification and removal of several trademarks, including 'MANJAL.' The court accepted the first respondent's affidavit stating that some trademarks had expired and others were not being put to use despite renewal. Consequently, the court allowed the petitions, directing the first respondent to initiate necessary cancellation applications before the Trade Marks Registry within a specified timeframe.
Pharmacyclics LlcvsDeputy Controller Of Patents And Designs
Pharmacyclics Llc appealed the Deputy Controller of Patents and Designs' decision dated March 5, 2024, which refused to grant a Patent under Section 15 of the Act. The appellant also filed an application seeking condonation of eight days delay in filing the appeal.
NakulvsVersuni India Home Solutions Limited
The court addressed several applications in the suit, including granting time for the plaintiff to file a replication. Crucially, the defendant filed a counterclaim under Section 64 of The Patents Act, 1970, seeking revocation of Indian Patent No. 319855. Additionally, the court allowed the defendant to submit prior art via an encrypted pen drive.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.